Edwards Lifesciences Corp. (EW)

Index:

S&P 500

$ 77.52
   
  • Change Today:
    $-0.25
  • 52 Week High: $93.78
  • 52 Week Low: $59.70
  • Currency: US Dollars
  • Shares Issued: 588.60m
  • Volume: 2,634,009
  • Market Cap: $45,628m
  • RiskGrade: 116
  • Beta: 0.55

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 5,439.50 5,010.00 5,282.40 5,232.50 4,386.30
Operating Profit/(Loss) 1,378.70 1,308.90 1,748.50 1,690.30 897.60
Profit Before Tax 1,548.10 1,372.40 1,767.40 1,702.00 916.70
Profit After Tax 1,396.00 1,220.00 1,521.90 1,503.10 823.40
           
Earnings per Share - Basic 234.00¢ 202.00¢ 246.00¢ 241.00¢ 132.00¢
Earnings per Share - Adjusted 234.00¢ 202.00¢ 246.00¢ 241.00¢ 132.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 1,784.20 1,675.40 1,725.10 1,638.70 1,489.40
Intangible Assets 2,953.30 1,544.50 1,449.50 1,491.50 1,504.60
Other Non-Current Assets 2,032.40 2,107.60 2,022.10 2,191.70 1,152.10
  6,769.90 5,327.50 5,196.70 5,321.90 4,146.10
Current Assets          
Inventories 1,086.70 903.50 875.50 726.70 802.30
Cash at Bank & in Hand 3,045.20 1,132.30 769.00 862.80 1,183.20
Other Current Assets 2,153.50 1,999.90 1,451.30 1,591.20 1,105.50
  6,285.40 4,035.70 3,095.80 3,180.70 3,091.00
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 13,055.30 9,363.20 8,292.50 8,502.60 7,237.10
Current Liabilities          
Borrowings 23.40 22.90 25.50 25.50 27.20
Other Current Liabilities 1,481.80 1,172.50 996.90 1,006.80 866.70
           
Current Liabilities 1,505.20 1,195.40 1,022.40 1,032.30 893.90
           
Net Current Assets c4,780.20 c2,840.30 c2,073.40 c2,148.40 c2,197.10
           
Borrowings 676.60 662.20 765.80 664.80 667.70
Other Non-Current Liabilities 810.60 786.20 797.60 969.60 1,101.20
Non-Current Liabilities 1,487.20 1,448.40 1,563.40 1,634.40 1,768.90
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 2,992.40 2,643.80 2,585.80 2,666.70 2,662.80
           
Net Assets 10,062.90 6,719.40 5,706.70 5,835.90 4,574.30
           
Shareholders Funds 9,998.40 6,650.00 5,706.70 5,835.90 4,574.30
           
Minority Interests/Other Equity 64.50 69.40 n/a n/a n/a
Total Equity 10,062.90 6,719.40 5,706.70 5,835.90 4,574.30
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 542.30 895.80 1,218.20 1,732.10 1,054.30
Net Cash Flow from Investing Activities 2,312.90 173.80 252.30 (1,722.50) (531.10)
Net Cash Flow from Financing Activities (944.40) (694.20) (1,565.30) (342.40) (507.40)
Net Increase/Decrease In Cash 1,910.80 375.40 (94.80) (332.80) 15.80
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 31.6 37.7 30.3 53.8 69.1
PEG - Adjusted 2.0 n/a 15.2 0.6 0.5
Earnings per Share Growth - Adjusted 16% -18% 2% 83% 136%
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 924.14¢ 851.17¢ 897.45¢ 888.97¢ 745.21¢
Pre-Tax Profit per Share 263.01¢ 233.16¢ 300.27¢ 289.16¢ 155.74¢
Operating Margin 25.35% 26.13% 33.10% 32.30% 20.46%
Return on Capital Employed 19.82% 23.42% 35.01% 33.81% 24.35%
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 92.13¢ 152.19¢ 206.97¢ 294.27¢ 179.12¢
Cash Incr/Decr per Share 324.63¢ 63.78¢ (16.11¢) (56.54¢) 2.68¢
Net Asset Value per Share (exc. Intangibles) 1,207.88¢ 879.19¢ 723.28¢ 738.09¢ 521.53¢
Net Gearing -23.46% -6.72% 0.39% -2.96% -10.67%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page